Stock VSBC VITASPRING BIOMEDICAL CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart VitaSpring Biomedical Co. Ltd.

Equities

VSBC

US92851B1026

Market Closed - OTC Markets
Other stock markets
 19:03:41 11/08/2023 BST 		5-day change 1st Jan Change
15 USD +36.24% Intraday chart for VitaSpring Biomedical Co. Ltd. -.--% -.--%
2022 VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022 CI
2022 VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VITASPRING BIOMEDICAL CO. LTD. Stock VitaSpring Biomedical Co. Ltd.
 3.11B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. VSBC Stock
  4. Charts VitaSpring Biomedical Co. Ltd.
  5. Sector Chart